HMMR and pancreatic adenocarcinoma: In contrast, pancreatic adenocarcinoma presents a reduction in the mean fold change in RHAMM expression (0.91), with a slightly higher median fold change (1.43), suggesting that RHAMM’s role may vary across different types of cancer.